Callicarpa kwangtungensis
Callicarpa kwangtungensis
Callicarpa kwangtungensis is a plant that has not been extensively used in traditional medicine. Scientific research indicates that poliumoside, a compound isolated from this plant, may alleviate neurological deficits and reduce infarct size in mice after ischemic stroke by modulating microglial polarization and reducing inflammation. Additionally, administration of CK led to significant improvements in cognitive function and reduced amyloid-beta and neurofibrillary tangle formation in APP/PS1 mice models. Six new metabolites with a 23-norursane triterpenoid skeleton were identified through fungal biotransformation, one of which showed potential vascular protective activity. No major safety issues or drug interactions have been recorded for this plant.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- Poliumoside alleviated neurological deficits and reduced infarct size in mice after ischemic stroke by modulating microglial polarization and reducing inflammation.
- The study identified potential alternative sources for traditional Callicarpa species used in medicinal preparations.
- CK administration led to significant improvements in cognitive function and reduced amyloid-beta and neurofibrillary tangle formation in APP/PS1 mice.
- Six new metabolites with a 23-norursane triterpenoid skeleton were identified through fungal biotransformation, and one showed potential vascular protective activity.
Frequently asked questions
What is Callicarpa kwangtungensis?
Callicarpa kwangtungensis (Callicarpa kwangtungensis) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Callicarpa kwangtungensis?
4 sourced findings are recorded for Callicarpa kwangtungensis; the strongest carries evidence grade D. For example: Poliumoside alleviated neurological deficits and reduced infarct size in mice after ischemic stroke by modulating microglial polarization and reducing inflammation.
How strong is the evidence for Callicarpa kwangtungensis?
The strongest finding for Callicarpa kwangtungensis carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Callicarpa kwangtungensis safe? What are the side effects?
No major safety issues are recorded for Callicarpa kwangtungensis in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Callicarpa kwangtungensis interact with medications?
No drug interactions are recorded for Callicarpa kwangtungensis in our sources. This does not rule them out — check with a pharmacist.
Is Callicarpa kwangtungensis a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Six undescribed 23-norursane triterpenoids from the biotransformation of ilexgenin a by endophytic fungi and their vascular protective activity. literature abstract metadata
- T2 Phytochemical analysis of different Callicarpa species based on integrating metabolomics and chemometrics. literature abstract metadata
- T2 Integrating network pharmacology and multi-omics to explore the mechanism of Callicarpa kwangtungensis Chun in ameliorating Alzheimer's disease pathology in APP/PS1 mice. literature abstract metadata
- T2 Poliumoside alleviates microglia-mediated inflammation and blood-brain barrier disruption via modulating the polarization of microglia after ischemic stroke in mice. literature abstract metadata